Retatrutide Injection: How It's Administered (Once Weekly)

Retatrutide injection follows the same once-weekly subcutaneous pattern that has made medications like semaglutide and tirzepatide so convenient for patients. Eli Lilly's investigational triple-agonist drug is administered with a small needle into the fatty tissue just beneath the skin, requiring only minutes per week. In Phase 2 clinical trials (Jastreboff et al., NEJM 2023), this dosing approach produced an average of 24.2% body weight loss at the highest dose — proving that one injection per week can deliver transformative results.

Once-Weekly Dosing Overview

Retatrutide is designed as a once-weekly injection. You choose one day per week as your injection day and administer the medication at approximately the same time each week. This schedule works because retatrutide has a half-life of approximately 6 days, meaning the drug maintains therapeutic levels in your bloodstream throughout the entire week.

Injection Site Selection

Three injection sites are used for subcutaneous GLP-1-based medications, and retatrutide follows the same pattern:

Abdomen

The most commonly used site. Inject into the fatty area of the abdomen, at least 2 inches (5 cm) away from the belly button. Avoid any areas with scars, bruises, or skin irregularities. The abdomen typically has consistent subcutaneous fat and is easy to access, making it the preferred site for most patients.

Front of the Thigh

The middle third of the front of the thigh provides another good injection site. This area is easily accessible and generally has adequate subcutaneous tissue. It is a good alternative for patients who prefer not to inject in the abdomen.

Back of the Upper Arm

The outer, upper area of the arm can also be used, though this site may require assistance from another person since it is harder to reach. It is best for patients whose provider or a family member administers the injection.

Rotating Injection Sites

Rotating between injection sites each week helps prevent lipodystrophy (changes in fat tissue at the injection site) and reduces the risk of skin irritation. A simple rotation pattern — for example, left abdomen, right abdomen, left thigh, right thigh — ensures even distribution.

Injection Technique

While specific retatrutide injection instructions will accompany the product if approved, the subcutaneous injection technique is standardized across GLP-1 medications:

1. Prepare the area: Clean the injection site with an alcohol swab and allow it to air dry
2. Prepare the medication: Follow the specific preparation steps for the injection device (pen or syringe)
3. Pinch the skin: Gently pinch a fold of skin at the injection site to lift subcutaneous tissue away from muscle
4. Insert the needle: At a 45-90 degree angle (depending on body composition), insert the needle fully into the pinched skin fold
5. Inject the medication: Slowly and steadily depress the plunger to deliver the full dose
6. Wait: Hold the needle in place for 5-10 seconds after injection to ensure complete delivery
7. Remove and dispose: Withdraw the needle and dispose of it in a sharps container

Delivery Device

In Phase 2 clinical trials, retatrutide was administered using prefilled syringes. If approved, Eli Lilly would likely offer retatrutide in an autoinjector pen similar to their tirzepatide (Mounjaro/Zepbound) delivery device. Autoinjector pens simplify the process by pre-measuring the dose and concealing the needle.

For patients who currently use compounded semaglutide or tirzepatide, the injection technique would be virtually identical to what they already know. The transition from one subcutaneous injectable to another is seamless.

Choosing Your Injection Day and Time

Selecting the right injection day and time can help minimize side effects and maximize convenience:

• Consistency matters: Choose a day you will remember week after week. Many patients tie it to a recurring event (e.g., every Monday morning)
• Consider side effects: GI side effects like nausea are most common in the first 24-48 hours after injection. Some patients prefer injecting on Friday evening so any nausea occurs over the weekend
• Time of day is flexible: Morning or evening both work. There is no evidence that time of day significantly affects efficacy
• With or without food: Subcutaneous injections are not affected by food in the stomach, so you can inject regardless of meal timing

Does the Injection Hurt?

Most patients describe subcutaneous GLP-1 injections as causing minimal discomfort — typically a brief pinch lasting 1-2 seconds. Several factors minimize pain:

• Small needle: Subcutaneous needles are very thin (typically 30-32 gauge), much smaller than those used for blood draws
• Shallow depth: The needle only needs to reach subcutaneous fat, not muscle, so insertion depth is minimal
• Small volume: The injection volume is small, reducing pressure and discomfort during delivery
• Cold numbing: Some patients apply an ice cube to the site for 30 seconds before injecting to reduce sensation

For patients who are needle-averse, it helps to know that clinical trial completion rates for retatrutide were high — the injection itself was not a significant reason for dropout. The inconvenience of one needle stick per week is minimal compared to the average 71 pounds of weight loss the drug produced.

Currently Available Injections

While waiting for retatrutide to potentially reach the market, the same injection technique is used for today's proven weight loss medications:

• Compounded semaglutide: Once-weekly subcutaneous injection, starting at $99/month
• Compounded tirzepatide: Once-weekly subcutaneous injection, starting at $125/month

Both use the same subcutaneous technique described above. Learn more about how TRIMI's process works from consultation to delivery, or see our cheapest legal GLP-1 online cornerstone for full provider pricing comparison vs Hims, Ro, Found, Mochi, Henry Meds, LillyDirect with 503A pharmacy compliance citations.